Sarfraz Shaikh

Statistics

Publications

Citations

1.8K

H-Index

Active since

2010

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Sarfraz Shaikh is an author at Alnylam Pharmaceuticals (United States) specializing in rna interference, molecular biology, and small interfering rna biology.

Publications per year

2010–2020

Publications

Multivalent <i>N</i>-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing

Jayaprakash K. Nair, Jennifer L. S. Willoughby, Amy Chan et al. · Journal of the American Chemical Society · 2014 · 1.1K citations

Pharmacy, Pharmaceutics, Pharmacology +17

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates

Donald J. Foster, Christopher R. Brown, Sarfraz Shaikh et al. · Molecular Therapy · 2018 · 308 citations · Full text

Pharmacy, Molecular Biology, Pharmacology +17

Promoter RNA links transcriptional regulation of inflammatory pathway genes

Masayuki Matsui, Yongjun Chu, Huiying Zhang et al. · Nucleic Acids Research · 2013 · 235 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR)

Yosef Landesman, Nenad Svrzikapa, Armand B. Cognetta et al. · Silence · 2010 · 58 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +15

RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models

Nadine Haase, Donald J. Foster, Mark Cunningham et al. · Journal of Clinical Investigation · 2020 · 42 citations · Full text

Medicine, Molecular Medicine, Pharmacology +17

1–5 of 7